Approval · Notice of Compliance 9685 · 2008
ADVAIR DISKUS: Notice of Compliance 9685
Issued July 18, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9685
- Date
- July 18, 2008
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph
- Therapeutic class
- Bronchodilator and cortisosteroid for oral inhalation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVAIR DISKUS | Not yet assigned | — |
Medicinal ingredients
- SALMETEROL XINAFOATE 50 MCG per DOSE
- FLUTICASONE PROPIONATE 500 MCG per DOSE